Montreux Capital Management (UK) (MCM UK) and three businesses within the Active Care Group portfolio have been nominated in various categories at the LaingBuisson Awards 2019.

LaingBuisson is the world’s leading healthcare business intelligence provider servicing clients for over 30 years which include providers, commissioners, investors and regulators. The LaingBussion Awards are a highlight of the health and social care calendar, recognising leading players within the industry.

MCM UK have been nominated for the Investor of the Year Award, recognising the business as one of the key actors in the sector and reflecting the purchase of several high-quality businesses in the space. Over the last twelve months MCM UK has transacted on: John Edwards Care Homes, Jane Lewis, Independence Care Homes, Remeo Healthcare, Medbank and AJ Case Management. These transactions have further cemented its place amongst the largest investors in the sector.The Active Care Group have also been nominated in the following categories:

  • Neural Pathways for Innovation in Care.
  • Independence Homes for Supported Living.
  • Active Assistance for Homecare.

Montreux Capital Management (UK), CEO, Oliver Harris, stated: “We are pleased to be recognised by LaingBuisson for our contributions to the health and social care market, our business has enjoyed an expanding investor base over the past twelve months, reflecting our responsible stewardship of capital over the last nine years.

The Active Care Group’s further three nominations are a strong endorsement of the progress the business has made and continues to make.”

The LaingBuisson Awards 2019 will take place on Wednesday 13th November at the Park Plaza Westminster Bridge, London. Further details and shortlisted finalists can be found on their website at:

Find Us

Thameside House
Hurst Road
East Molesey

T: + 44 (0) 1932 860 140

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.